阿昔洛韦与垂盆草治疗乙型肝炎的比较  

Aciclovir vs Sedum sarmentosum in treating hepatitis B

作　　者：杨金龙[1] 匡云山[1] 荣雅秋 吕萍[1] 郑水根[1] 

机构地区：[1]上海市第八人民医院传染科

出　　处：《新药与临床》1994年第3期175-176,共2页

摘　　要：静脉滴注阿昔洛韦治疗慢性乙型肝炎患者３１例（男性２１例，女性１０例；年龄３３±ｓ６ａ），７５０ｍｇ，ｑｄ，共１ｍｏ。另２０例（男性１８例，女性２例；年龄３５±７ａ），口服垂盆草冲剂为对照，１０ｇ，ｔｉｄ，共１ｍｏ。结果：ＨＢｅＡｇ阴转率，前者为４５％，后者为０（Ｐ＜０．０１）；ＡＬＴ复常率，前者为７９％，后者为７０％（Ｐ＞０．０５）。Thirty-one pathents(M21.F10;age 33 ± s 6 a) with chronic hepatitis B were treated with aciclovir 750 mg in Ringer's solution 500 mL iv,gtt.qd for 1 mo.Another similar 20 patients(M18.F2;age 35±7 a) received Sedum sarmentosum 10 g,po、tid for 1 mo.Results showed that the negative conversion rate of HBeAg were 45% and 0,restpectively(P<0.01).while the reversion of abnormal ALT activity were 79% and 70%,respectively(P>0.05).

关 键 词：阿昔洛韦 乙型肝炎 垂盆草 

分 类 号：R978.7[医药卫生—药品]